BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Taking Aim at Melanoma - The Scientist - Magazine of the Life Sciences
News | 04. 01. 2011
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.